These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19090928)

  • 1. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
    Işgör YG; Kiliç Z; Olgen S
    Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new indole and bromoindole derivatives as pp60(c-Src) tyrosine kinase inhibitors.
    Kiliç Z; Işgör YG; Olgen S
    Chem Biol Drug Des; 2009 Oct; 74(4):397-404. PubMed ID: 19691468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.
    Olgen S; Isgör YG; Coban T
    Arch Pharm (Weinheim); 2008 Feb; 341(2):113-20. PubMed ID: 18214841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R; Daga PR; Banerjee R; Iqbal J
    Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
    Alvarez RH; Kantarjian HM; Cortes JE
    Cancer; 2006 Oct; 107(8):1918-29. PubMed ID: 16986126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
    Han NM; Curley SA; Gallick GE
    Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of novel 2,3-diaryl-substituted 5-cyano-4-azaindoles exhibiting c-Met inhibition activity.
    Koolman H; Heinrich T; Böttcher H; Rautenberg W; Reggelin M
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1879-82. PubMed ID: 19269177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of noise-induced hearing loss with Src-PTK inhibitors.
    Harris KC; Hu B; Hangauer D; Henderson D
    Hear Res; 2005 Oct; 208(1-2):14-25. PubMed ID: 15950415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitors.
    Noronha G; Barrett K; Cao J; Dneprovskaia E; Fine R; Gong X; Gritzen C; Hood J; Kang X; Klebansky B; Li G; Liao W; Lohse D; Mak CC; McPherson A; Palanki MS; Pathak VP; Renick J; Soll R; Splittgerber U; Wrasidlo W; Zeng B; Zhao N; Zhou Y
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5546-50. PubMed ID: 16931012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent dipeptide inhibitors of the pp60c-src SH2 domain.
    Pacofsky GJ; Lackey K; Alligood KJ; Berman J; Charifson PS; Crosby RM; Dorsey GF; Feldman PL; Gilmer TM; Hummel CW; Jordan SR; Mohr C; Shewchuk LM; Sternbach DD; Rodriguez M
    J Med Chem; 1998 May; 41(11):1894-908. PubMed ID: 9599239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
    Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
    Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP60c-src expression in osteoclasts from osteopetrotic children and in giant tumor cells.
    Trubert CL; Bernard F; Hivroz C; Carlioz A; Fischer A; Cournot G
    Eur J Histochem; 1997; 41(3):169-76. PubMed ID: 9359028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.
    Masaki T; Okada M; Shiratori Y; Rengifo W; Matsumoto K; Maeda S; Kato N; Kanai F; Komatsu Y; Nishioka M; Omata M
    Hepatology; 1998 May; 27(5):1257-64. PubMed ID: 9581679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.